FJ
FORMELA JEAN FRANCOIS Other
US US · SEC (Form 4)
Browse the full record of transactions filed by FORMELA JEAN FRANCOIS. Director active across 3 companies, notably Intellia Therapeutics, Inc.. In total, 11 disclosures have been published. Total volume traded: €145.3m. The latest transaction was filed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations 11 total
05,197 shares 0
Common Stock
SEC:0001209191-22-037598:0 · 14 Jun 2022
€2m 125,000 shares @ €13.6477 100.0% of flow
Common Stock
SEC:0001209191-21-069645 · 30 Mar 2021
Ideal exit: 25 Dec 2021 (T+270) €2m 125,000 shares @ €13.6477 50.0% of flow
Common Stock
SEC:0001209191-21-069645:0 · 30 Mar 2021
Ideal exit: 25 Dec 2021 (T+270) €66m 2,055,063 shares @ €32.1898 100.0% of flow
Common Stock
SEC:0001209191-21-056045 · 14 Sept 2021
€66m 2,055,063 shares @ €32.1898 50.0% of flow
Common Stock
SEC:0001209191-21-056045:0 · 14 Sept 2021
€3m 26,019 shares @ €106.4809 0.15% mcap 57.7% of flow
Common Stock
SEC:0001104659-21-086607 · 28 Jun 2021
€3m 26,019 shares @ €106.4809 0.15% mcap 28.8% of flow
Common Stock
SEC:0001104659-21-086607:0 · 28 Jun 2021
02,094 shares 0
Common Stock
SEC:0001209191-21-043374 · 23 Jun 2021
02,094 shares 0
Common Stock
SEC:0001209191-21-043374:0 · 23 Jun 2021
€2m 29,071 shares @ €69.9771 0.11% mcap 42.3% of flow
Common Stock
SEC:0001104659-21-081255 · 11 Jun 2021
€2m 29,071 shares @ €69.9771 0.11% mcap 21.2% of flow
Common Stock
SEC:0001104659-21-081255:0 · 11 Jun 2021
About FORMELA JEAN FRANCOIS FORMELA JEAN FRANCOIS is a director at Intellia Therapeutics, Inc. and also holds insider roles at Translate Bio, Inc. and Ikena Oncology, Inc.